Literature DB >> 21732009

Membrane proteins: the key players of a cancer cell.

Kim R Kampen1.   

Abstract

Membrane proteins are involved in the prognosis of the most common forms of cancer. Membrane proteins are the hallmark of a cancer cell. The overexpressed membrane receptors are becoming increasingly important in cancer cell therapy. Current renewing therapy approaches based on receptor overexpression include; antibody therapy, nanocarrier drug delivery, and fluorescent tumor imaging in surgery. Gene profiling reveals cancer specific signatures and may identify membrane proteins that are related to cancer progression and lead to the development of improved therapy strategies in the future.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732009     DOI: 10.1007/s00232-011-9381-7

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  44 in total

1.  Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer.

Authors:  Jin Hee Maeng; Don-Haeng Lee; Kyung Hee Jung; You-Han Bae; In-Suh Park; Seok Jeong; Yong-Sun Jeon; Chang-Koo Shim; Wooyoung Kim; Jungahn Kim; Jeongmi Lee; Yoon-Mi Lee; Ji-Hee Kim; Won-Hong Kim; Soon-Sun Hong
Journal:  Biomaterials       Date:  2010-03-26       Impact factor: 12.479

2.  Monitoring response and resistance to treatment in chronic myeloid leukemia.

Authors:  S Assouline; J H Lipton
Journal:  Curr Oncol       Date:  2011-04       Impact factor: 3.677

3.  Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712.

Authors:  Jennifer A Woyach; Amy S Ruppert; Nyla A Heerema; Bercedis L Peterson; John G Gribben; Vicki A Morrison; Kanti R Rai; Richard A Larson; John C Byrd
Journal:  J Clin Oncol       Date:  2011-02-14       Impact factor: 44.544

4.  TRIO-012: a multicenter, multinational, randomized, double-blind phase III study of IMC-1121B plus docetaxel versus placebo plus docetaxel in previously untreated patients with HER2-negative, unresectable, locally recurrent or metastatic breast cancer.

Authors:  John Mackey; Karen Gelmon; Miguel Martin; Nicole McCarthy; Tamas Pinter; Mathieu Rupin; Hagop Youssoufian
Journal:  Clin Breast Cancer       Date:  2009-11       Impact factor: 3.225

5.  Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.

Authors:  Peter M Smith-Jones; Neeta Pandit-Taskar; Wei Cao; Joseph O'Donoghue; Martin D Philips; Jorge Carrasquillo; Jason A Konner; Lloyd J Old; Steven M Larson
Journal:  Nucl Med Biol       Date:  2008-04       Impact factor: 2.408

6.  Loss of CD59 expression in breast tumours correlates with poor survival.

Authors:  Z Madjd; S E Pinder; C Paish; I O Ellis; J Carmichael; L G Durrant
Journal:  J Pathol       Date:  2003-08       Impact factor: 7.996

7.  Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.

Authors:  Lakshmi Sampath; Sunkuk Kwon; Shi Ke; Wei Wang; Rachel Schiff; Michel E Mawad; Eva M Sevick-Muraca
Journal:  J Nucl Med       Date:  2007-09       Impact factor: 10.057

8.  Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.

Authors:  Jerome F Sah; Sivaprakasam Balasubramanian; Richard L Eckert; Ellen A Rorke
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

Review 9.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

Review 10.  Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC).

Authors:  Giulio Metro; Giovanna Finocchiaro; Luca Toschi; Stefania Bartolini; Elisabetta Magrini; Alessandra Cancellieri; Rocco Trisolini; Luciano Castaldini; Giovanni Tallini; Lucio Crino; Federico Cappuzzo
Journal:  Rev Recent Clin Trials       Date:  2006-01
View more
  32 in total

1.  A Cell-Surface Membrane Protein Signature for Glioblastoma.

Authors:  Dhimankrishna Ghosh; Cory C Funk; Juan Caballero; Nameeta Shah; Katherine Rouleau; John C Earls; Liliana Soroceanu; Greg Foltz; Charles S Cobbs; Nathan D Price; Leroy Hood
Journal:  Cell Syst       Date:  2017-03-29       Impact factor: 10.304

2.  Aptamer TY04 inhibits the growth of multiple myeloma cells via cell cycle arrest.

Authors:  Hongjuan Dai; Mao Ye; Mingyuan Peng; Weihua Zhou; Huarong Bai; Xiaojuan Xiao; Bianying Ma; Jiajie Zhou; Shijun Tang; Shan Yao; Ye Cao; Zhiqiang Qin; Jing Liu; Weihong Tan
Journal:  Tumour Biol       Date:  2014-05-03

Review 3.  Cell membrane-derived nanomaterials for biomedical applications.

Authors:  Ronnie H Fang; Yao Jiang; Jean C Fang; Liangfang Zhang
Journal:  Biomaterials       Date:  2017-03-01       Impact factor: 12.479

4.  Targeting Tumor-Associated Exosomes with Integrin-Binding Peptides.

Authors:  Randy P Carney; Sidhartha Hazari; Tatu Rojalin; Alisha Knudson; Tingjuan Gao; Yuchen Tang; Ruiwu Liu; Tapani Viitala; Marjo Yliperttula; Kit S Lam
Journal:  Adv Biosyst       Date:  2017-04-03

5.  Mass spectrometry based proteomics for absolute quantification of proteins from tumor cells.

Authors:  Hong Wang; Sam Hanash
Journal:  Methods       Date:  2015-03-17       Impact factor: 3.608

6.  Targeted-TERS detection of integrin receptors on human cancer cells.

Authors:  Lifu Xiao; Zachary D Schultz
Journal:  Cancer Cell Microenviron       Date:  2016-09-12

Review 7.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Rapid LC-MS Method for Accurate Molecular Weight Determination of Membrane and Hydrophobic Proteins.

Authors:  Jennifer L Lippens; Pascal F Egea; Chris Spahr; Amit Vaish; James E Keener; Michael T Marty; Joseph A Loo; Iain D G Campuzano
Journal:  Anal Chem       Date:  2018-10-31       Impact factor: 6.986

9.  Electrochemical aptamer-based determination of protein tyrosine kinase-7 using toehold-mediated strand displacement amplification on gold nanoparticles and graphene oxide.

Authors:  Zongbing Li; Zhengkun Zhou; Ning Xue; Shujie Wu; Xiangmin Miao
Journal:  Mikrochim Acta       Date:  2019-10-26       Impact factor: 5.833

10.  Surface Expression of Kynurenine 3-Monooxygenase Promotes Proliferation and Metastasis in Triple-Negative Breast Cancers.

Authors:  Min-Hua Lai; Chi-Hsun Liao; Nu-Man Tsai; Kai-Fu Chang; Cheng-Chi Liu; Yi-Han Chiu; Kuo-Ching Huang; Chen-Si Lin
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.